Rioprostil in the Acute and Long-Term Treatment of Peptic Ulcers: A Review

References

• Euler A R, Tytgat G, Berenguer J, Brunner H, Wood D R, Lookabaugh J L, Phan T D. Failure of a cytoprotective dose of arbaprostil to heal acute duodenal ulcers. Gastroenterology 1987; 92: 604–607
   PubMed Web of Science ®Google Scholar
• Dammann H G, Walter Th A, Dau B, Muller P, Simon B. 1987
   Google Scholar
• O'Keefe S JD, Spitaels J-M, Mannion G, Naiker N. Misoprostol, a synthetic prostaglandin E, analogue, in the treatment of duodenal ulcers. South A M J 1985; 67: 321–324
   PubMed Web of Science ®Google Scholar
• Hunt R, Chiverton S W, Place K, Dickson B. Clinical developments on misoprostol: peptic ulcer disease and NSAID-induced gastropathy. Chicago May 8, 1987, Abstracts 8–9
   Google Scholar
• Lauritsen K, Havelund T, Laursen L S, Bytzer P, Kjaergaard J, Rask-Madsen J, Enprostil and ranitidine in the prevention of duodenal ulcer relapse, a one year double-blind comparative trial
   Google Scholar
• Bardhan K D. Omeprazole in the treatment of erosive esophatitis (EE) refactory to high dose cime-tidine. Gastroenterology 1987; 92: 1306
   Web of Science ®Google Scholar
• Bardhan K D, Whittaker L, Hinchliffe R FC, Cleur K, Bose K. Trimoprostil vs cimetidine in duodenal ulcer. Gut 1984; 25: 580
   Web of Science ®Google Scholar
• Bardhan K D, Bose K, Hinchliffe R FC, Whittaker L, Morris P, Massey H, Thomson M. Enprostil (E) versus ranitidine (R) in duodenal ulcer (DU). Gut 1985; 26: A1149
   Web of Science ®Google Scholar
• Hentschel E, Bounameaux Y, Kratochuil P, Koch H, Ottenjann R, Van Ongevalle P. Z Gastro-enterologie 1985; 23: 445
   Google Scholar
• Lauritsen K, Laursen L S, Havelund T, Bytzer P, Svendsen L B, Rask-Madsen J. Enprostil and ranitidine in duodenal ulcer healing: double-blind comparative trial. Br Med J 1986; 292: 864–866
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Chapman J W, Nicholson P A. A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients. Dig Dis Sci 1986; 31: 75S–80S
   Web of Science ®Google Scholar
• Shield M J. Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers. Dig Dis Sci 1985; 30: 178S–184S
   Google Scholar
• Nicholson P A. A multicenter internationally controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients. Dig Dis Sci 1985; 30: 171S–177S
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Janssens J, Popiela T, et al. Effect of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on the healing of duodenal ulcer. Gastroenterology 1982; 83: 357–363
   PubMed Web of Science ®Google Scholar
• Winters L. Comparison of enprostil and cimetidine Rioprostil and Peptic Ulcer 211 in active duodenal ulcer disease. Summary of pooled European studies. Am J Med 1986; 81: 69–74
   PubMed Web of Science ®Google Scholar
• Dammann H G, Huttemann W, Kalek H D, Rohner H G, Simon B. Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. Am J Med 1986; 81(suppl 2A)80–84
   PubMed Web of Science ®Google Scholar
• Walt R P, Long R G, Logan R FA, Somerville K W, Langman M JS, Hawkey C J. Double blind clinical trial comparing night time enprostil with ranitidine in duodenal ulcer. Gut 1986; 27: A608
   Web of Science ®Google Scholar
• Roth S H. Clinical developments on misoprostol: peptic ulcer disease and NSAID-induced gastropathy. Chicago May 8, 1987; 22–23, Abstracts
   Google Scholar
• Silverstein F E. Clinical developments on misoprostol: peptic ulcer disease and NSAID-induced gastropathy. Chicago May 8, 1987; 16–17, Abstracts
   Google Scholar
• Dammann H G, Simon-Schultz J, Bauermeister W, Schmoldt A, Müller P, Simon B. Prevention of NSAID-induced gastric ulcer with prostaglandin analogues. Lancet 1989; I: 52
   Google Scholar
• Bianchi-Porro G, Parente R, Hentschel E, et al. Rioprostil in the short-term treatment of duodenal ulcer: a multicentre double-blind trial vs. cimetidine. Scand J Gastroenterol 1989; 24(suppl 164)221–225
   Google Scholar
• Coremans G, Vantrappen G, Businger J A, Demol P, et al. Efficacy and safety of rioprostil, 300 μg b.d., in the treatment of duodenal ulcer: a double-blind controlled multicentre clinical study vs. ranitidine. Scand J Gastroenterol 1989; 24(suppl 164)198–206
   Google Scholar
• Lavignolle A, Raillat A, Slama J L, et al. Rioprostil vs. ranitidine in duodenal ulcer healing: a double blind multi-center trial. Scand J Gastroenterol 1989; 24(suppl 164)194–197
   Google Scholar
• Businger J A, Miglio F, Gasbarrini T, et al. Rioprostil, a new prostaglandin E1 analogue, in the once daily treatment of acute duodenal ulcer: a comparison with ranitidine. Scand J Gastroenterol 1989; 24(suppl 164)161–168
   Google Scholar
• Whorwell P J. Rioprostil in the healing of duodenal ulceration. Scand J Gastroenterol 1989; 24(suppl 164)214
   Google Scholar
• Quinton A, Goldfain D, Weber F, et al. Treatment of benign gastric ulcer: a comparative clinical trial of rioprostil and ranitidine. Scand J Gastroenterol 1989; 24(suppl 164)178–183
   Google Scholar
• Rutgeerts P, Vantrappen G, Businger J A, et al. Efficacy and safety of rioprostil, 300μg b.d., in the treatment of gastric ulcer: a comparison vs. ranitidine, 150 mg b.d., in a randomized multicentre study. Scand J Gastroenterol 1989; 24(suppl 164)184–190
   Google Scholar
• Businger J A, Fumagalli I, Michel H, Delas N, Stocker H. Rioprostil, a new prostaglandin E, analogue, in the once-daily treatment for the prevention of duodenal ulcer recurrence: A comparison with ranitidine. Scand J Gastroenterol 1989; 24(suppl 164)152–160
   Google Scholar
• Rampal P, Raillat A, Vitean J M, et al. Rioprostil and ranitidine in the prevention of duodenal ulcer relapse. Scand J Gastroenterol 1989; 24(suppl 164)146–151
   Google Scholar